EWM
PCRX icon

Empirical Wealth Management’s Pacira BioSciences PCRX Stock Holding History

Empirical Wealth Management’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$619K Buy
24,413
+2,154
+10% +$50.9K 0.01% 591
2026
Q1 		$503K Buy
22,259
+6,944
+45% +$154K 0.01% 569
2025
Q4 		$396K Buy
15,315
+2,358
+18% +$56.1K 0.01% 596
2025
Q3 		$334K Buy
+12,957
New +$318K 0.01% 582

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Empirical Wealth Management's PCRX Position: Q2 2026 in Review

Empirical Wealth Management increased its Pacira BioSciences (PCRX) stake by 9.7% in Q2 2026, buying an estimated $50.9K and bringing the position to 24,413 shares worth $619K. The position accounts for 0.01% of the portfolio, ranked #591.

Empirical Wealth Management first reported a position in PCRX in Q3 2025 and has held it in 4 quarters since. 254 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

  • Empirical Wealth Management held 24,413 shares of Pacira BioSciences worth $619K as of Q2 2026.
  • Empirical Wealth Management bought 2,154 Pacira BioSciences shares in Q2 2026, an estimated $50.9K.
  • Pacira BioSciences made up 0.01% of Empirical Wealth Management's portfolio in Q2 2026, its #591 holding.
  • Empirical Wealth Management first reported a position in Pacira BioSciences in Q3 2025 and has held it in 4 quarters since.
  • 254 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on Empirical Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.